Tag: SyneuRx

SyneuRx reveals results of COVID-19 candidate trial

by John Pinching | Aug 8, 2022 | News | 0

Positive data show Pentarlandir is safe and effective in patients with mild-to-moderate COVID-19

Read More

PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN

E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999